A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation
- Nat Commun. 2017 Oct 27;8(1):1150. doi: 10.1038/s41467-017-01243-7.
- 1. Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, 48109, USA.
- 2. Department of Pathology, University of Michigan, Ann Arbor, Michigan, 48109, USA.
- 3. Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, 48109, USA.
- 4. Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310029, China.
- 5. Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, 48109, USA.
- 6. Department of Oncological Sciences, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, New York, 10029, USA.
- 7. Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, 48109, USA. [email protected].
- 8. Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, 48109, USA. [email protected].
- 9. Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan, 48109, USA. [email protected].
The Cullin-RING E3 ubiquitin ligases (CRLs) regulate homeostasis of ~20% of cellular proteins and their activation require neddylation of their cullin subunit. Cullin neddylation is modulated by a scaffolding DCN protein through interactions with both the cullin protein and an E2 enzyme such as UBC12. Here we report the development of DI-591 as a high-affinity, cell-permeable small-molecule inhibitor of the DCN1-UBC12 interaction. DI-591 binds to purified recombinant human DCN1 and DCN2 proteins with K i values of 10-12 nM, and disrupts the DCN1-UBC12 interaction in cells. Treatment with DI-591 selectively converts cellular cullin 3 into an un-neddylated inactive form with no or minimum effect on Other cullin members. Our data firmly establish a previously unrecognized specific role of the DCN1-UBC12 interaction for cellular neddylation of cullin 3. DI-591 is an excellent probe compound to investigate the role of the cullin 3 CRL Ligase in biological processes and human diseases.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: E1/E2/E3 EnzymeResearch Areas: Cancer